CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction" The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus INTERMACS Profiles and Outcomes Among Non–Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection Fraction Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure Dapagliflozin for treating chronic heart failure with reduced ejection fraction Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is Assessed The spectrum of heart failure: value of left ventricular ejection fraction and its moving trajectories

Original Research2018 May 15;137(20):2101-2103.

JOURNAL:Circulation. Article Link

Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study

Januzzi JL Jr, Richards AM. Keywords: biomarkers; evidence-based medicine; guideline adherence; heart failure; natriuretic peptides

LINK


Please click on the "Article Link" to access the article.